Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol in maintenance hemodialysis patients with secondary hyperparathyroidism
ChiCTR2100054241Phase 4Recruiting
- Sponsor
- Ya'an People's Hospital
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paricalcitol in secondary hyperparathyroidism (SHPT), sponsored by Ya'an People's Hospital. Primary endpoints: Serum calcium, Serum phosphorus and 2 more. Started Dec 2019; status: recruiting.
02
Drugs
paricalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on ChiCTR2100054241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054241.